SurModics Company Profile (NASDAQ:SRDX)

About SurModics (NASDAQ:SRDX)

SurModics logoSurmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:SRDX
  • CUSIP: 86887310
  • Web:
  • Market Cap: $316.63 million
  • Outstanding Shares: 13,276,000
Average Prices:
  • 50 Day Moving Avg: $23.29
  • 200 Day Moving Avg: $24.41
  • 52 Week Range: $21.70 - $30.75
  • Trailing P/E Ratio: 33.69
  • Foreward P/E Ratio: 37.27
  • P/E Growth: 6.16
Sales & Book Value:
  • Annual Revenue: $73.39 million
  • Price / Sales: 4.31
  • Book Value: $8.24 per share
  • Price / Book: 2.89
  • EBIDTA: $21.68 million
  • Net Margins: 13.46%
  • Return on Equity: 13.14%
  • Return on Assets: 10.69%
  • Current Ratio: 9.55%
  • Quick Ratio: 8.97%
  • Average Volume: 45,932 shs.
  • Beta: 1.03
  • Short Ratio: 16.59

Frequently Asked Questions for SurModics (NASDAQ:SRDX)

What is SurModics' stock symbol?

SurModics trades on the NASDAQ under the ticker symbol "SRDX."

How were SurModics' earnings last quarter?

SurModics, Inc. (NASDAQ:SRDX) posted its quarterly earnings data on Thursday, April, 27th. The company reported $0.05 EPS for the quarter, missing the Zacks' consensus estimate of $0.07 by $0.02. The company earned $17.50 million during the quarter, compared to analyst estimates of $16.21 million. SurModics had a return on equity of 13.14% and a net margin of 13.46%. SurModics's revenue was up 4.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.20 earnings per share. View SurModics' Earnings History.

When will SurModics make its next earnings announcement?

SurModics is scheduled to release their next quarterly earnings announcement on Wednesday, July, 26th 2017. View Earnings Estimates for SurModics.

What guidance has SurModics issued on next quarter's earnings?

SurModics issued an update on its FY17 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $0.15-0.25 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.32. The company issued revenue guidance of $65-68 million, compared to the consensus revenue estimate of $67.15 million.

Where is SurModics' stock going? Where will SurModics' stock price be in 2017?

2 brokers have issued 12-month price targets for SurModics' stock. Their predictions range from $33.00 to $33.00. On average, they expect SurModics' share price to reach $33.00 in the next twelve months. View Analyst Ratings for SurModics.

Are investors shorting SurModics?

SurModics saw a decline in short interest during the month of April. As of April 13th, there was short interest totalling 549,710 shares, a decline of 1.9% from the March 31st total of 560,093 shares. Based on an average daily volume of 50,132 shares, the short-interest ratio is currently 11.0 days.

Who are some of SurModics' key competitors?

Who owns SurModics stock?

SurModics' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Wellington Management Group LLP (8.89%), Trigran Investments Inc. (8.10%), Renaissance Technologies LLC (7.58%), Vanguard Group Inc. (5.25%), Dimensional Fund Advisors LP (4.54%) and Royce & Associates LP (2.78%). Company insiders that own SurModics stock include Bryan K Phillips, Charles W Olson, Gary R Maharaj, Joseph J Stich, Susan E Knight and Timothy J Arens. View Institutional Ownership Trends for SurModics.

Who sold SurModics stock? Who is selling SurModics stock?

SurModics' stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Acadian Asset Management LLC, Menta Capital LLC, Schwab Charles Investment Management Inc., Oxford Asset Management, Credit Suisse AG, Segall Bryant & Hamill LLC and Teachers Advisors LLC. Company insiders that have sold SurModics stock in the last year include Bryan K Phillips, Charles W Olson, Gary R Maharaj, Joseph J Stich and Susan E Knight. View Insider Buying and Selling for SurModics.

Who bought SurModics stock? Who is buying SurModics stock?

SurModics' stock was purchased by a variety of institutional investors in the last quarter, including Trigran Investments Inc., Wellington Management Group LLP, Royce & Associates LP, Renaissance Technologies LLC, Citadel Advisors LLC, Vanguard Group Inc., AQR Capital Management LLC and Nine Chapters Capital Management LLC. View Insider Buying and Selling for SurModics.

How do I buy SurModics stock?

Shares of SurModics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of SurModics stock cost?

One share of SurModics stock can currently be purchased for approximately $23.85.

Analyst Ratings

Consensus Ratings for SurModics (NASDAQ:SRDX) (?)
Ratings Breakdown: 2 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $33.00 (38.36% upside)

Analysts' Ratings History for SurModics (NASDAQ:SRDX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/21/2016Barrington ResearchDowngradeOutperform -> Market PerformN/AView Rating Details
10/6/2016SidotiDowngradeBuy -> Neutral$33.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for SurModics (NASDAQ:SRDX)
Earnings by Quarter for SurModics (NASDAQ:SRDX)
Earnings History by Quarter for SurModics (NASDAQ:SRDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/27/2017Q2 2017$0.07$0.05$16.21 million$17.50 millionViewN/AView Earnings Details
2/2/2017Q117$0.09$0.19$15.81 million$17.80 millionViewListenView Earnings Details
11/16/2016Q4 2016$0.09$0.26$16.09 million$18.20 millionViewListenView Earnings Details
7/28/2016Q316$0.12$0.37$16.31 million$19.97 millionViewListenView Earnings Details
5/2/2016Q2$0.09$0.20$14.71 million$16.70 millionViewListenView Earnings Details
1/28/2016Q116$0.17$0.38$14.58 million$16.50 millionViewListenView Earnings Details
11/10/2015Q415$0.19$0.30$15.30 million$17.40 millionViewListenView Earnings Details
8/5/2015Q315$0.21$0.26$14.86 million$15.90 millionViewListenView Earnings Details
4/30/2015Q2$0.20$0.19$14.09 million$14.40 millionViewListenView Earnings Details
1/29/2015Q414$0.21$0.25$14.30 million$14.20 millionViewListenView Earnings Details
11/6/2014Q314$0.25$0.26$14.90 million$15.30 millionViewN/AView Earnings Details
7/31/2014Q214$0.23$0.27$14.84 million$14.62 millionViewListenView Earnings Details
5/1/2014Q114$0.20$0.22$14.40 million$13.60 millionViewListenView Earnings Details
1/30/2014Q413$0.21$0.21$14.15 million$13.90 millionViewListenView Earnings Details
11/5/2013Q313$0.22$0.26$14.32 million$14.30 millionViewListenView Earnings Details
7/31/2013Q3 2013$0.21$0.22$15.03 million$14.29 millionViewListenView Earnings Details
5/7/2013Q2 2013$0.21$0.20$13.92 million$13.70 millionViewListenView Earnings Details
1/30/2013Q1 2013$0.18$0.29$13.63 million$13.85 millionViewListenView Earnings Details
11/6/2012Q412$0.17$0.17$13.83 million$13.80 millionViewN/AView Earnings Details
8/1/2012$0.14$0.17ViewN/AView Earnings Details
5/8/2012$0.15$0.14ViewN/AView Earnings Details
11/3/2011$0.05$0.06ViewN/AView Earnings Details
8/3/2011$0.04$0.13ViewN/AView Earnings Details
4/27/2011$0.08ViewN/AView Earnings Details
1/26/2011$0.05ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for SurModics (NASDAQ:SRDX)
2017 EPS Consensus Estimate: $0.19
2018 EPS Consensus Estimate: $0.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.05$0.12$0.09
Q2 20172$0.05$0.08$0.07
Q3 20172$0.00$0.03$0.02
Q4 20172$0.01$0.04$0.03
Q1 20181$0.07$0.07$0.07
Q2 20181$0.06$0.06$0.06
Q3 20181$0.06$0.06$0.06
Q4 20181$0.07$0.07$0.07
(Data provided by Zacks Investment Research)


Dividend History for SurModics (NASDAQ:SRDX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for SurModics (NASDAQ:SRDX)
Insider Ownership Percentage: 6.40%
Institutional Ownership Percentage: 85.59%
Insider Trades by Quarter for SurModics (NASDAQ:SRDX)
Institutional Ownership by Quarter for SurModics (NASDAQ:SRDX)
Insider Trades by Quarter for SurModics (NASDAQ:SRDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/3/2017Gary R. MaharajCEOSell584$25.00$14,600.00View SEC Filing  
3/6/2017Joseph J. StichVPSell1,000$24.73$24,730.00View SEC Filing  
12/22/2016Charles W OlsonVPSell1,201$26.00$31,226.00View SEC Filing  
12/8/2016Charles W OlsonVPSell3,699$26.02$96,247.98View SEC Filing  
12/5/2016Joseph J StichVPSell1,000$23.97$23,970.00View SEC Filing  
12/2/2016Bryan K PhillipsSVPSell1,264$23.90$30,209.60View SEC Filing  
11/25/2016Charles W OlsonVPSell500$26.02$13,010.00View SEC Filing  
11/7/2016Gary R MaharajCEOSell5,000$25.22$126,100.00View SEC Filing  
10/3/2016Gary R. MaharajCEOSell5,000$29.55$147,750.00View SEC Filing  
8/17/2016Charles W OlsonVPSell9,936$28.98$287,945.28View SEC Filing  
8/15/2016Susan E. KnightDirectorSell1,548$28.64$44,334.72View SEC Filing  
8/1/2016Charles W OlsonVPSell12,500$27.08$338,500.00View SEC Filing  
6/14/2016Bryan K PhillipsSVPSell1,816$23.44$42,567.04View SEC Filing  
6/10/2016Joseph J StichVPSell1,000$23.33$23,330.00View SEC Filing  
5/27/2016Susan E KnightDirectorSell1,001$22.71$22,732.71View SEC Filing  
3/4/2016Timothy J ArensVPSell10,291$18.43$189,663.13View SEC Filing  
12/4/2015Joseph J StichVPSell1,000$21.18$21,180.00View SEC Filing  
9/4/2015Joseph J StichVPSell1,000$23.57$23,570.00View SEC Filing  
6/5/2015Joseph J StichVPSell1,000$23.84$23,840.00View SEC Filing  
5/22/2015Bryan K PhillipsSVPSell7,293$25.25$184,148.25View SEC Filing  
12/29/2014Charles W OlsonVPSell5,083$21.98$111,724.34View SEC Filing  
12/8/2014Charles W OlsonVPSell3,365$21.66$72,885.90View SEC Filing  
11/19/2014Timothy J ArensVPSell10,330$21.02$217,136.60View SEC Filing  
5/8/2014Susan KnightDirectorBuy1,500$20.36$30,540.00View SEC Filing  
12/4/2013Bryan PhillipsSVPSell16,236$22.95$372,616.20View SEC Filing  
5/15/2013Mark A LehmanInsiderSell1,693$26.55$44,949.15View SEC Filing  
8/10/2012Value Lp StarboardMajor ShareholderSell257,560$17.74$4,569,114.40View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for SurModics (NASDAQ:SRDX)
Latest Headlines for SurModics (NASDAQ:SRDX)
DateHeadline logoSurmodics to Present at Upcoming Investor Conferences - May 22 at 8:51 AM logoETFs with exposure to SurModics, Inc. : May 5, 2017 - May 5 at 10:21 PM logoSurModics (SRDX) Given Daily Media Impact Score of 0.17 - May 3 at 9:24 PM logoSurModics, Inc. :SRDX-US: Earnings Analysis: Q2, 2017 By the Numbers : May 3, 2017 - May 3 at 6:10 PM logoSurModics, Inc. (SRDX) Downgraded by Zacks Investment Research - May 1 at 5:16 PM logoSurModics, Inc. to Post Q3 2017 Earnings of $0.00 Per Share, Barrington Research Forecasts (SRDX) - May 1 at 8:48 AM logoSomewhat Positive Media Coverage Extremely Likely to Affect SurModics (SRDX) Share Price - April 30 at 2:41 PM logoSurModics, Inc. (SRDX) Short Interest Update - April 29 at 7:51 AM logoSurModics, Inc. (SRDX) Issues Earnings Results - April 28 at 7:38 PM logoSurModics, Inc. breached its 50 day moving average in a Bearish Manner : SRDX-US : April 28, 2017 - April 28 at 4:13 PM logoEdited Transcript of SRDX earnings conference call or presentation 27-Apr-17 12:30pm GMT - April 28 at 1:16 AM logoSurmodics Q2 Profit Falls, Narrows FY17 Earnings View - April 27 at 8:15 PM logoSurmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance - April 27 at 8:15 PM logoSurModics posts 2Q profit - April 27 at 8:15 PM logoSurModics, Inc. (SRDX) Posts Earnings Results, Misses Expectations By $0.02 EPS - April 27 at 7:05 PM logoSomewhat Positive Media Coverage Extremely Likely to Affect SurModics (SRDX) Stock Price - April 27 at 2:01 PM logoSurModics, Inc. (SRDX) Updates FY17 Earnings Guidance - April 27 at 10:59 AM logoSurModics (SRDX) Earning Somewhat Critical Media Coverage, Report Finds - April 24 at 2:44 PM logo$16 Million in Sales Expected for SurModics, Inc. (SRDX) This Quarter - April 20 at 12:14 PM logoSurModics, Inc. – Value Analysis (NASDAQ:SRDX) : April 19, 2017 - April 19 at 7:58 PM logo$0.06 EPS Expected for SurModics, Inc. (SRDX) This Quarter - April 18 at 8:29 PM logoSurModics (SRDX) Earning Somewhat Favorable Press Coverage, Analysis Finds - April 18 at 3:42 PM logoSurmodics to Webcast Second Quarter 2017 Earnings Conference Call on April 27 - April 18 at 9:02 AM logoSurModics, Inc. breached its 50 day moving average in a Bullish Manner : SRDX-US : April 18, 2017 - April 18 at 9:02 AM logoZacks: SurModics, Inc. (SRDX) Receives Average Rating of "Buy" from Brokerages - April 18 at 12:32 AM logoSurmodics Appoints Lisa Wipperman Heine to Its Board of Directors - April 17 at 8:53 AM logoSurModics (SRDX) Receiving Favorable Press Coverage, Report Finds - April 15 at 10:07 AM logoSurModics, Inc. breached its 50 day moving average in a Bullish Manner : SRDX-US : April 4, 2017 - April 7 at 12:45 PM logoSurModics, Inc. (SRDX) CEO Gary R. Maharaj Sells 584 Shares - April 5 at 9:18 PM logo SurModics, Inc. (SRDX) Given $34.63 Average Price Target by Brokerages - March 30 at 12:14 PM logoSurmodics to Present at Oppenheimer Healthcare Conference - March 14 at 7:28 PM logoSurModics, Inc. (SRDX) VP Joseph J. Stich Sells 1,000 Shares - March 8 at 11:54 PM logoWhy Is Surmodics (SRDX) Down 2.7% Since the Last Earnings Report? - March 8 at 8:12 AM logoSURMODICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders - February 17 at 7:26 PM logoEdited Transcript of SRDX earnings conference call or presentation 2-Feb-17 1:30pm GMT - February 4 at 2:25 AM logoQ1 2017 Surmodics Inc Earnings Release - Before Market Open - February 3 at 5:40 AM logoSurmodics Reports First Quarter Fiscal 2017 Results - February 3 at 5:40 AM logo7:36 am Surmodics beats by $0.10, beats on revs; raises FY17 rev guidance, narrows EPS guidance - February 3 at 5:40 AM logoSurmodics to Webcast First Quarter 2017 Earnings Conference Call on February 2 - January 25 at 6:08 AM logoSURMODICS INC Financials - December 8 at 9:02 PM logoSURMODICS INC Files SEC form 10-K, Annual Report - December 6 at 8:29 AM logoSURMODICS INC Files SEC form 8-K, Change in Directors or Principal Officers - November 29 at 10:22 AM logoSurmodics to Attend Piper Jaffray Healthcare Conference - November 22 at 12:18 PM logoEdited Transcript of SRDX earnings conference call or presentation 16-Nov-16 1:30pm GMT - November 17 at 11:52 AM logoSurModics (SRDX) Beats Q4 Earnings & Revenues Estimates - November 17 at 11:52 AM logoSurmodics Q4 Profit Rises; Sees FY17 Earnings Below Estimates - Quick Facts - November 16 at 11:29 AM logoSurmodics to Present at Canaccord Genuity Medical Technology and Diagnostics Forum - November 9 at 10:28 AM logoSURMODICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Ag - November 7 at 8:31 PM logoSurmodics downgraded by Sidoti - October 6 at 7:09 PM logoSurmodics Inc (SRDX.O) - September 23 at 11:49 AM



SurModics (SRDX) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff